Blog
The AMCP Blog is your go-to resource to hear from managed care experts and their perspectives on trends and hot topics related to managed care pharmacy.
In the world of health care innovation, speed matters. But when it comes to developing and deploying cutting-edge treatments and therapeutics safely, a cautious and methodical approach is vital as well. Safety matters as much as speed, but faster doesn’t always mean riskier. In her latest blog, AMCP CEO Susan Cantrell discusses the history of the Pre-approval Information Exchange (PIE) Act and how it will help patients.
On Nov. 9, 2022, Cliff Goodman, PhD, moderated the AMCP Summit on value-based arrangements. He provides his key takeaways from the virtual event in the latest guest blog.
With Congress back to work after the midterm elections, AMCP remains focused on the critical window that remains to pass important pieces of health legislation this year. In this blog post, AMCP CEO Susan Cantrell provides an exciting update on our legislative priority, the Pre-Approval Information Exchange (PIE) Act.
In this guest blog post, AMCP Summit moderator Lionel Phillips explores themes discussed during the health disparities summit.
In June we conducted our inaugural AMCP Summit on Addressing Health Disparities. Enjoy 10 key takeaways from this virtual event.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
During AMCP 2022 in March, Dr. Kali Cyrus lead a workshop titled: A Primer on Bias from Discovery to Implementing Strategies to Address. AMCP CEO, Susan Cantrell explores the highlights from this workshop and how managed care professionals may be able to implement Dr. Cyrus' strategies in their day-to-day.
In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
On May 18, 2022, AMCP hosted Legislative Days where AMCP members and the AMCP Policy and Government Relations team met virtually with U.S. Senators and Representatives to advocate for AMCP's top policy priorities. Learn more about the role Legislative Days plays in achieving our mission to improve patient health by ensuring access to high-quality, cost-effective medications and other therapies.
AMCP CEO, Susan Cantrell, MHL, RPh, CAE, highlights AMCP's strategic priority to address racial disparities.
In this guest blog post, Tenicia Talley, PharmD, MSCR, discussespharmacoequity and how this applies to AMCP's efforts in addressing racial health disparities.
